{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreiesu6mejhetff5krlgvtio6dg37dkd6lz3nkc2dyyui6pvro5yubu",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mmmangcgpwd2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreig55kxiynsvu5zbldtej6jf6hdjvgip2xpy44ca5yawogoh6xo744"
    },
    "mimeType": "image/jpeg",
    "size": 328516
  },
  "path": "/news/2026-05-blood-biomarkers-earliest-alzheimer-disease.html",
  "publishedAt": "2026-05-24T10:30:03.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "Alzheimer's disease, a progressive neurodegenerative disorder that affects millions worldwide, has a long preclinical stage. It potentially begins decades before clinical symptoms become apparent.",
  "title": "Blood biomarkers could detect earliest signs of Alzheimer's disease—and slow its progression"
}